Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study

Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study

BackgroundPartial dopamine D2 receptor agonists are used for psychotic symptoms in adults with schizophrenia spectrum disorders. Recently, interest surged for partial dopamine D2 receptor agonists in substance use disorders (SUDs). Since it is believed that SUDs decrease the efficacy of pharmacother...

Full description

Bibliographic Details
Main Authors: Ginevra Lombardozzi, Giada Trovini, Emanuela Amici, Georgios D. Kotzalidis, Filippo Perrini, Valeria Giovanetti, Alessandro Di Giovanni, Sergio De Filippis
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Psychiatry
Subjects:
antipsychotic medications
brexpiprazole
partial dopamine D2 receptor agonists
schizophrenia
substance use disorder
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1321233/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1321233/full

Similar Items